U.S. Stock Analyst Ratings for 1/21/2019
 

BrokerageActionCompany NameCurrent
Price
Price
Target
RatingImpact on
Share Price
Actions
Credit Suisse Group ReiteratesLam Research (LRCX)$194.44 $278.00BuyHighView Rating Details  Share on Twitter  Share on StockTwits
Raymond James ReiteratesMacroGenics (MGNX)$16.77SellHighView Rating Details  Share on Twitter  Share on StockTwits
Royal Bank of Canada ReiteratesMicrosoft (MSFT)$125.39 $124.00BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
Goldman Sachs Group ReiteratesNetflix (NFLX)$381.06 $450.00BuyHighView Rating Details  Share on Twitter  Share on StockTwits
Jefferies Financial Group ReiteratesQiagen (QGEN)$38.66NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
Wells Fargo & Co ReiteratesSemGroup (SEMG)$14.29HoldHighView Rating Details  Share on Twitter  Share on StockTwits
Previous Week  |  Jan 21  |  Jan 22  |  Jan 23  |  Jan 24  |  Jan 25  |  Next Week

Always Get the Latest U.S. Stock Analyst Ratings: Stay ahead of the market with MarketBeat.com's daily email update that provides a summary of analysts' upgrades, downgrades and new coverage. Click here to register.

This page was last refreshed on Tuesday at 04:04 PM ET.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel